LOINC CMS survey codes
CMS survey (SURVEY.CMS): one class of the LOINC code system.
968 codes · page 19 of 20 · every class · by category · by group · panels · answer lists · parts
Recall - bed during assessment period (qualitative) 103701-9 Temporal orientation - current day of the week (qualitative) 103703-5 Brief Interview for Mental Status - summary score during assessment period 103704-3 Mood interview total severity score during assessment period 103705-0 Staff assessment of resident mood total severity score during assessment period 103707-6 Race during assessment period 103708-4 How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy during assessment period (qualitative) 103709-2 I have indicated all the devices needed during assessment period (qualitative) 105177-0 Site of Service at Admission during assessment period 106631-5 Patient ZIP Code during assessment period 106632-3 Date the patient or responsible party was first asked about preference regarding the use of CPR during assessment period 106635-6 Was the patient or responsible party asked about preference regarding the use of cardiopulmonary resuscitation during assessment period (qualitative) 106637-2 Was the patient or responsible party asked about preferences regarding life-sustaining treatments other than CPR during assessment period (qualitative) 106639-8 Date the patient or responsible party was first asked about preferences regarding life-sustaining treatments other than CPR during assessment period 106640-6 Date the patient and or caregiver was first asked about spiritual or existential concerns during assessment period 106642-2 Was the patient and or caregiver asked about spiritual or existential concerns during assessment period (qualitative) 106643-0 Date the patient or responsible party was first asked about preference regarding hospitalization during assessment period 106645-5 Was the patient or responsible party asked about preference regarding hospitalization during assessment period (qualitative) 106646-3 Principal Diagnosis during assessment period 106647-1 Comorbidities and Co-existing Conditions during assessment period 106649-7 Death is Imminent during assessment period (qualitative) 106664-6 Was the patient screened for pain during assessment period (qualitative) 106665-3 Date of first screening for pain during assessment period 106666-1 Patient's pain severity during assessment period (qualitative) 106667-9 Was a comprehensive pain assessment done during assessment period (qualitative) 106668-7 Type of standardized pain tool used during assessment period 106669-5 Pain Active Problem during assessment period (qualitative) 106670-3 Date of comprehensive pain assessment during assessment period 106672-9 Comprehensive pain assessment included during assessment period 106673-7 Neuropathic Pain during assessment period (qualitative) 106674-5 Was the patient screened for shortness of breath during assessment period (qualitative) 106676-0 Date of first screening for shortness of breath during assessment period 106677-8 Did the screening indicate the patient had shortness of breath during assessment period (qualitative) 106678-6 Was treatment for shortness of breath initiated during assessment period (qualitative) 106680-2 Date treatment for shortness of breath initiated during assessment period 106681-0 Date of symptom impact screening during assessment period 106683-6 Was a symptom impact screening completed during assessment period (qualitative) 106684-4 Symptom Impact - Pain during assessment period (qualitative) 106688-5 Symptom Impact - Shortness of breath during assessment period (qualitative) 106689-3 Symptom Impact - Anxiety during assessment period (qualitative) 106690-1 Symptom Impact - Vomiting during assessment period (qualitative) 106691-9 Symptom Impact - Nausea during assessment period (qualitative) 106692-7 Symptom Impact - Diarrhea during assessment period (qualitative) 106693-5 Symptom Impact - Constipation during assessment period (qualitative) 106694-3 Symptom Impact - Agitation during assessment period (qualitative) 106695-0 SFV Symptom Impact - Agitation during assessment period (qualitative) 106696-8 SFV Symptom Impact - Constipation during assessment period (qualitative) 106697-6 SFV Symptom Impact - Diarrhea during assessment period (qualitative) 106698-4 SFV Symptom Impact - Vomiting during assessment period (qualitative) 106699-2 SFV Symptom Impact - Nausea during assessment period (qualitative) 106700-8